Zydus Wellness Ltd Q4 FY2022 Concall Summary

Key Takeaways

• Muted volume, margin squeeze: Net sales grew 5.7% but volume rose only 0.4%, while gross margin dropped 350 bps for the full year as input costs surged.
• Summer brands poised for recovery: Glucon-D and Nycil lost an estimated 8-9% of annual revenue in each of the last two years to COVID waves; an early summer and normalized season offer a path to reclaim lost consumers.
• Complan is the open wound: The brand lost share to 5.0% as the category degrew 2% in Q4 and the leader cut price; management is relaunching and testing pouches but explicitly will not follow the leader's price-down strategy.
• Debt-free milestone in sight: The company expects to be debt-free on a gross basis by June-July 2023, a clear near-term balance-sheet catalyst.
• What to watch next quarter: Whether the summer stickiness thesis holds as two years of habit disruption meet inflationary pressure on rural demand, and whether Complan's relaunch can arrest the share slide without matching competitor pricing.

Summer Portfolio: The Recovery Bet

• Two-year COVID hit: The company's summer-heavy brands lost an estimated 8-9% of total annual revenue each year in FY21 and FY22 because COVID waves struck during their peak summer selling window, disrupting a category where consumers typically buy only 1.5 packs per season and must be re-recruited each year.
• Early Q4 traction: An early set-in of summer in Q4 helped Glucon-D post double-digit growth for the full year and maintain its 58.5% market share; Nycil held its #1 position at 33.7% share despite the second consecutive year of impact.
• Distribution rebuild underway: Glucon-D distribution fell from a peak of Rs. 16-17 lakhs to Rs. 12 lakhs trailing because the category shrank 30% in 2020 and has not fully regained ground; management hopes this year will see the highest ever distribution number for the brand.
• Nycil gaining numeric heft: Volume share rose from 29% pre-acquisition to 37% after three years as direct distribution, total reach, and weighted distribution all increased; management is optimistic the brand can drive category growth and gain further share even if competition intensifies.
• Stickiness is the unknown: Two years of habit disruption may have permanently moved some consumers away from seasonal categories; management acknowledges the early start is positive but says it is "very difficult to predict what happens for the full summer."

Dr. Sharvil Patel: "we have to wait and see that this business remains sticky because two years the habit formation may have changed in consumers and they would have moved away from something. So, I think it has been a good start, but we have to wait and see."

Complan: Share Loss & Strategic Divergence

• Category in reverse: The HFD category slowed over three quarters and degrew 2% in Q4; Complan's market share stood at 5.0%, driven partly by price drops taken by the category leader in launching a pouch pack.
• Relaunch without price war: The brand was relaunched with improved taste, new pack design, and campaigns focused on memory and concentration; management is testing pouch and sachet segments but explicitly stated "we are not following the leader strategy" on price cuts.
• Milk inflation compounds the problem: Complan is the one brand where cost issues are not fully covered by price increases, and milk prices continue to zoom higher; management may need to respond to competitive pricing even as input costs rise, squeezing margins further.
• Distribution gains as offset: Complan gained 25-30% in distribution reach post-acquisition, which drove high double-digit growth over 3-4 quarters before demand-side headwinds hit.

Tarun Arora: "We are not following the leader strategy. What we are doing is actually 2 or 3 things, one in the re-launch, we have focused on the brand building where we are focusing on the proposition around overall growth which is beyond physical growth that we stood for. We are focusing on memory and concentration."

Margin & Input Cost Dynamics

• Full-year margin erosion: Gross margin dropped 350 bps despite price increases covering most brands, driven by product mix impacts and reduced volume across FMCG; EBITDA was down 0.1% year-on-year to Rs. 133.3 crores.
• Price increase coverage: An estimated 7.5% price increase was taken, of which 5.3% has played out; the remaining portion is yet to flow through assuming the same mix and planned volumes.
• Sequential improvement in Q4: Gross margin improved 265 bps sequentially as price increases and cost improvement measures began to bite; management expects further improvement through a mix of initiatives in coming quarters.
• Inflation still accelerating: FY22 raw material inflation was 2.5-3%; in Q1 it went up by another 4%, with key inputs like milk and refined palm oil on a continuously rising trend with no sign of abatement.
• Intent vs. volatility: Management's intent is for gross margins to revert to around 55-56%, but the CFO called the environment "absolutely very volatile" and refused to commit to a timeline, noting that the Ukraine crisis and crude-led packaging cost spikes emerged mid-quarter.
• Operating leverage as the second engine: Beyond gross margin recovery, management is counting on full revenue realization to unlock operating leverage; the hope is that directionally the operating margin line moves in the right direction this year, but "last few quarters have taught us that you can plan for something and it can be different."

Tarun Arora: "Our intent is to be doing that, but hard to say because every quarter, we are seeing some new challenges and very hard to predict the way the world is changing. It is absolutely very volatile."

Portfolio Breadth: The Other Engines

• Distribution as the common thread: The last distribution drive from Rs. 3.4 lakhs to about Rs. 5.5 lakhs outlets completed 13-14 months ago delivered high double-digit growth on Complan, good growth in Everyuth, and value gains in sweeteners; a further 100,000 direct points are planned this year with an aspiration to hit 0.1 crore over the next couple of years.
• Channel shift underway: Modern trade and e-commerce are growing faster than GT, pushing organized trade share from 14% to 18%; this structurally increases working capital days, which management expects to normalize around 20-22 days from the current 26.

Demand Environment & Down-Trading

• GT muted, organized trade growing: The last couple of quarters saw demand-side impact with HFD categories degrowing 2%; general trade was subdued while organized trade grew, shifting channel mix.
• Down-trading visible: Nycil's Rs. 10 price point (20 gram pack) is doing very well; Everyuth sachets continue to grow; a Glucon-D sachet was launched in a limited way; some down-trading in HFD is driven by competitive actions, though movement toward lower unit packs also reflects consumer preference for measured doses.
• Rural saliency as a risk: Rural saliency is reasonably high for Glucon-D and Nycil, and is rising for Sugarfree, Everyuth, and Complan; management is "worried if the rural is struggling" but believes distribution expansion may overcome the headwind.

Tarun Arora: "rural will become increasingly more important and it therefore worries me if the rural is struggling, but I think by our focus on improving our distribution, doing the right things, we may be able to overcome this."

Guidance & Commitments

Key Metrics